Current status: 1052 hESC lines, 6669 hiPSC lines, and 165 clinical studies, and 2381 certificates
Monthly statistic from Dec 1, 2024
Posted on December 1, 2024
| total lines | 7721 |
| hESC lines | 1052 |
| hiPSC lines | 6669 |
| derivation countries | 50 |
| projects | 310 |
| providers | 945 |
| clinical studies | 165 |
| subclones | 3245 |
| certificates | 2381 |
| cell line certificates | 2234 |
| project certificates | 147 |